Pushkal Garg insider trades: Alnylam Pharmaceuticals (ALNY) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Pushkal reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | ALNY | ↓ Sell | 4,713 | $323.53 | $1.5M | Direct | Mar 6, 2026 (1d) |
| Mar 3, 2026 | ALNY | ↓ Sell | 3,492 | $323.63 | $1.1M | Direct | Mar 4, 2026 (1d) |
| Feb 27, 2026 | ALNY | ↓ Sell | 4,627 | $331.34 | $1.5M | Direct | Mar 2, 2026 (3d) |
| Feb 13, 2026 | ALNY | ↓ Sell | 2,242 | $310.08 | $695K | Direct | Feb 17, 2026 (4d) |
| Jan 12, 2026 | ALNY | ↓ Sell | 1,510 | $362.87 | $548K | Direct | Jan 14, 2026 (2d) |
| Oct 3, 2025 | ALNY | ↓ Sell | 5,959 | $451.76 | $2.7M | Direct | Oct 3, 2025 (0d) |
| Aug 19, 2025 | ALNY | ↓ Sell | 2,851 | $455.89 | $1.3M | Direct | Aug 19, 2025 (0d) |
| Mar 24, 2025 | ALNY | ↓ Sell | 9,766 | $293.36 | $2.9M | Direct | Mar 25, 2025 (1d) |
| Mar 4, 2025 | ALNY | ↓ Sell | 2,557 | $242.92 | $621K | Direct | Mar 5, 2025 (1d) |
| Feb 28, 2025 | ALNY | ↓ Sell | 935 | $241.69 | $226K | Direct | Mar 3, 2025 (3d) |
| Feb 18, 2025 | ALNY | ↓ Sell | 3,109 | $253.43 | $788K | Direct | Feb 18, 2025 (0d) |
| Jan 27, 2025 | ALNY | ↓ Sell | 52,592 | $285.00 | $15.0M | Direct | Jan 29, 2025 (2d) |
| Dec 12, 2024 | ALNY | ↓ Sell | 1,752 | $251.00 | $440K | Direct | Dec 13, 2024 (1d) |
| Nov 26, 2024 | ALNY | ↓ Sell | 1,682 | $250.98 | $422K | Direct | Nov 27, 2024 (1d) |
| Jun 25, 2024 | ALNY | ↓ Sell | 2,103 | $230.99 | $486K | Direct | Jun 26, 2024 (1d) |
| Feb 28, 2024 | ALNY | ↓ Sell | 574 | $155.30 | $89K | Direct | Feb 29, 2024 (1d) |
| Feb 16, 2024 | ALNY | ↓ Sell | 1,308 | $148.06 | $194K | Direct | Feb 20, 2024 (4d) |
| Aug 7, 2023 | ALNY | ↓ Sell | 7,627 | $184.78 | $1.4M | Direct | Aug 7, 2023 (0d) |
| Apr 28, 2023 | ALNY | ↓ Sell | 4,294 | $197.12 | $846K | Direct | Apr 28, 2023 (0d) |
| Mar 3, 2023 | ALNY | ↓ Sell | 18,072 | $200.00 | $3.6M | Direct | Mar 7, 2023 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ALNY insiders
Open-market trades in the last 12 months
About Pushkal Garg's insider trades
Pushkal Garg is EVP Chief R&D at Alnylam Pharmaceuticals (ALNY). Since Mar 3, 2023, Pushkal has reported no open-market purchases and 20 sales worth $36.4M on SEC Form 4. In the last 12 months: 5 sales ($5.4M).
Their filings also include grants and awards (21 filings), option exercises (6 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALNY insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.